Scotia Capital Inc. Organon & Co. Transaction History

Scotia Capital Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $274,973 - $356,113	-9,591 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $161,244 - $200,724	-5,632 Reduced 37.0%	9,591 $314,000
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $433,094 - $578,474	15,223 New	15,223 $461,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Scotia Capital Inc. with notifications on news.